Autolus Therapeutics Plc (AUTL)
1.19
-0.04
(-3.64%)
USD |
NASDAQ |
Nov 12, 16:00
1.21
+0.02
(+1.68%)
After-Hours: 07:07
Autolus Therapeutics EPS Diluted (Quarterly) : -0.2068 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2068 |
| June 30, 2026 | -0.1472 |
| March 31, 2026 | -0.2686 |
| December 31, 2025 | -0.3389 |
| September 30, 2025 | -0.2954 |
| June 30, 2025 | -0.1823 |
| March 31, 2025 | -0.2636 |
| December 31, 2024 | -0.1028 |
| September 30, 2024 | -0.3085 |
| June 30, 2024 | -0.219 |
| March 31, 2024 | -0.2372 |
| December 31, 2023 | -0.4434 |
| September 30, 2023 | -0.262 |
| June 30, 2023 | -0.2629 |
| March 31, 2023 | -0.2311 |
| December 31, 2022 | -0.1569 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.4687 |
| June 30, 2022 | -0.4625 |
| March 31, 2022 | -0.4077 |
| December 31, 2021 | -0.4583 |
| September 30, 2021 | -0.4663 |
| June 30, 2021 | -0.4683 |
| March 31, 2021 | -0.5327 |
| December 31, 2020 | -0.8188 |
| September 30, 2020 | -0.7163 |
| June 30, 2020 | -0.6158 |
| March 31, 2020 | -0.5991 |
| December 31, 2019 | -0.9102 |
| September 30, 2019 | -0.6122 |
| June 30, 2019 | -0.653 |
| March 31, 2019 | -0.6886 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | -0.1497 |
| Biodexa Pharmaceuticals Plc | -- |
| argenx SE | -- |
| NuCana Plc | -1.007 |
| Mereo BioPharma Group Plc | -0.0364 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.06M |
| Revenue (Quarterly) | 41.22M |
| Total Expenses (Quarterly) | 96.28M |
| Enterprise Value | 508.24M |
| Gross Profit Margin (Quarterly) | 56.53% |
| Profit Margin (Quarterly) | -133.6% |
| Earnings Yield | -80.80% |
| Normalized Earnings Yield | -80.72 |